Literature DB >> 27091712

Statistical Challenges in the Analysis of Health-Related Quality of Life in Cancer Clinical Trials.

Franck Bonnetain1, Frédéric Fiteni2, Fabio Efficace2, Amélie Anota2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27091712     DOI： 10.1200/JCO.2014.56.7974

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

Review 1.  Patient-Reported Outcomes with Chimeric Antigen Receptor T Cell Therapy: Challenges and Opportunities.

Authors:  Rajshekhar Chakraborty; Surbhi Sidana; Gunjan L Shah; Michael Scordo; Betty K Hamilton; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-28       Impact factor: 5.742

2.  Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab.

Authors:  Max S Topp; Zachary Zimmerman; Paul Cannell; Hervé Dombret; Johan Maertens; Anthony Stein; Janet Franklin; Qui Tran; Ze Cong; Andre C Schuh
Journal:  Blood       Date:  2018-05-08       Impact factor: 22.113

3.  Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review.

Authors:  E Charton; B Cuer; F Cottone; F Efficace; C Touraine; Z Hamidou; F Fiteni; F Bonnetain; M-C Woronoff-Lemsi; C Bascoul-Mollevi; A Anota
Journal:  Qual Life Res       Date:  2019-11-27       Impact factor: 4.147

4.  Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin.

Authors:  Omeed Moaven; Konstantinos I Votanopoulos; Perry Shen; Paul Mansfield; David L Bartlett; Greg Russell; Richard McQuellon; John H Stewart; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2019-11-12       Impact factor: 5.344

5.  Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.

Authors:  Yih-Lin Chung; Newman N M Pui
Journal:  Support Care Cancer       Date:  2017-03-28       Impact factor: 3.603

6.  Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions.

Authors:  Andrew Walding; Konstantina Skaltsa; Montserrat Casamayor; Anna Rydén
Journal:  Qual Life Res       Date:  2022-01-31       Impact factor: 3.440

Review 7.  Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report.

Authors:  Eric Van Cutsem; Aimery De Gramont; Geoffrey Henning; Philippe Rougier; Franck Bonnetain; Thomas Seufferlein
Journal:  Cancers (Basel)       Date:  2017-05-26       Impact factor: 6.639

Review 8.  Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review.

Authors:  Ahmad Ousmen; Célia Touraine; Nina Deliu; Francesco Cottone; Franck Bonnetain; Fabio Efficace; Anne Brédart; Caroline Mollevi; Amélie Anota
Journal:  Health Qual Life Outcomes       Date:  2018-12-11       Impact factor: 3.186

9.  Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial.

Authors:  Zeinab Hamidou; Benoist Chibaudel; Mohamed Hebbar; Marine Hug de Larauze; Thierry André; Christophe Louvet; David Brusquant; Marie-Line Garcia-Larnicol; Aimery de Gramont; Franck Bonnetain
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

Review 10.  Impact of enzalutamide on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives.

Authors:  Jia Luo; Julie N Graff
Journal:  Res Rep Urol       Date:  2016-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.